Robert F. Kennedy Jr. Plans to Continue Earning from Vaccine Litigation Amid HHS Secretary Nomination

Robert F. Kennedy Jr., HHS Secretary nominee, aims to maintain financial ties to litigation against Merck despite potential conflicts of interest.

C 67%
R 33%

Overview

A summary of the key points of this story verified across multiple sources.

Robert F. Kennedy Jr., nominated as HHS Secretary by President Trump, seeks to continue collecting fees from Wisner Baum, a law firm suing Merck over the Gardasil vaccine. This decision raises ethics concerns due to his ongoing financial interest in vaccine-related lawsuits while regulating the pharmaceutical industry, prompting scrutiny in his upcoming Senate confirmation hearing. Kennedy disclosed significant earnings, including $856,559 from the law firm, and plans to divest from other investments, but intends to keep a role in non-U.S. related cases.

Written using shared reports from
6 sources
.
Report issue

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Analysis unavailable for this viewpoint.

Sources (6)

Compare how different news outlets are covering this story.

History

See how this story has evolved over time.

This story does not have any previous versions.